Arrow Begins Non-Pulsatile VAD Trial, Targets Mid-Year LionHeart CE Mark
This article was originally published in The Gray Sheet
Executive Summary
Arrow International will commence a 15-patient pilot trial of its centrifugal flow ventricular assist device in Europe by the end of February, the firm announced during its annual stockholders meeting Jan. 15
You may also be interested in...
Arrow’s LionHeart To Receive New Power Source; U.S. Trial Awaits EU Testing
A European pilot study of Arrow International's CorAide continuous-flow ventricular assist system is expected to resume by year-end, following ongoing bench testing of modifications, the firm says
Arrow’s LionHeart To Receive New Power Source; U.S. Trial Awaits EU Testing
A European pilot study of Arrow International's CorAide continuous-flow ventricular assist system is expected to resume by year-end, following ongoing bench testing of modifications, the firm says
SynCardia To Bring TAH Ventricular Replacement Before FDA Panel In March
SynCardia's CardioWest Total Artificial Heart (TAH) will be reviewed by FDA's Circulatory System Devices panel March 17 in Gaithersburg, Md